Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

March 1, 1980; Volume 124,Issue 3

OPINION

  • You have accessRestricted access
    Information overload in immunology: possible solutions to the problem of excessive publication.
    B H Waksman
    J Immunol March 1, 1980, 124 (3) 1009-1015;

ARTICLES

  • You have accessRestricted access
    Cyclic AMP modulation of Fc receptor expression on a pre-B cell lymphoma.
    S W Burchiel and N L Warner
    J Immunol March 1, 1980, 124 (3) 1016-1021;
  • You have accessRestricted access
    Immunosuppression by 334C murine leukemia virus: viral specificity and the activation of immunosuppressive effects during cloned viral leukemogenesis.
    M K Robinson, K F Manly and M J Evans
    J Immunol March 1, 1980, 124 (3) 1022-1027;
  • You have accessRestricted access
    Effects of N alpha-tosyl-L-lysyl-chloromethylketone on the activity of cytotoxic T lymphocytes.
    T W Chang and H N Eisen
    J Immunol March 1, 1980, 124 (3) 1028-1033;
  • You have accessRestricted access
    Control of autologous immune complex nephritis. I. Suppression of the disease in the presence of T cell sensitization.
    W E Harmon, W E Grupe and R Parkman
    J Immunol March 1, 1980, 124 (3) 1034-1038;
  • You have accessRestricted access
    Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    C C Ting and D Rodrigues
    J Immunol March 1, 1980, 124 (3) 1039-1044;
  • You have accessRestricted access
    In vitro induction of cytotoxic T lymphocytes specific for Epstein-Barr virus-transformed cells: kinetics of autologous restimulation.
    K Sugamura and Y Hinuma
    J Immunol March 1, 1980, 124 (3) 1045-1049;
  • You have accessRestricted access
    Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect.
    D Boraschi and M S Meltzer
    J Immunol March 1, 1980, 124 (3) 1050-1053;
  • You have accessRestricted access
    Human T lymphcytes are enriched for transfer factor.
    R H Tomar and P A John
    J Immunol March 1, 1980, 124 (3) 1054-1057;
  • You have accessRestricted access
    T-T cell interactions during in vitro cytotoxic T lymphocyte (CTL) responses. II. Helper factor from activated Lyt 1+ T cells is rate limiting i) in T cell responses to nonimmunogenic alloantigen, ii) in thymocyte responses to allogeneic stimulator cells, and III) recruits allo- or H-2-restricted CTL precursors from the Lyt 123+ T subset.
    H Wagner, M Räollinghoff, K Pfizenmaier, C Hardt and G Johnscher
    J Immunol March 1, 1980, 124 (3) 1058-1067;
  • You have accessRestricted access
    Specific clonal regulation in the response to phosphocholine. I. Genetic analysis of the response of a distinct idiotype (M511 Id).
    V J Ruppert, K Williams and J L Claflin
    J Immunol March 1, 1980, 124 (3) 1068-1074;
  • You have accessRestricted access
    Ia antigen on the surface of a subfraction of T cells that bear Fc receptors for IgG.
    P A Kaszubowski, J S Goodwin and R C Williams Jr
    J Immunol March 1, 1980, 124 (3) 1075-1078;
  • You have accessRestricted access
    Cellular and genetic control of antibody responses. VIII. MHC restricted recognition of accessory cells, not B cells, by parent-specific subpopulations of normal F1 T helper cells.
    A Singer, K S Hathcock and R J Hodes
    J Immunol March 1, 1980, 124 (3) 1079-1085;
  • You have accessRestricted access
    Localization of the P2 protein in peripheral nerve myelin.
    E H Eylar, I Szymanska, A Ishaque, J Ramwani and S Dubiski
    J Immunol March 1, 1980, 124 (3) 1086-1092;
  • You have accessRestricted access
    Cellular requirements for generation of thymocyte stimulatory factor and characterization of its target cell.
    M L Thoman and W O Weigle
    J Immunol March 1, 1980, 124 (3) 1093-1099;
  • You have accessRestricted access
    Mechanisms of immune lysis. I. Physiological distinction between target cell death mediated by cytotoxic T lymphocytes and antibody plus complement.
    J H Russell, V R Masakowski and C B Dobos
    J Immunol March 1, 1980, 124 (3) 1100-1105;
  • You have accessRestricted access
    Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells.
    D N Männel, J J Farrar and S E Mergenhagen
    J Immunol March 1, 1980, 124 (3) 1106-1110;
  • You have accessRestricted access
    Cytotoxic T cells generated in the autologous mixed lymphocyte reaction. I. Primary autologous mixed lymphocyte reaction.
    K Tomonari
    J Immunol March 1, 1980, 124 (3) 1111-1121;
  • You have accessRestricted access
    Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.
    A R Anwar, J R McKean, S R Smithers and A B Kay
    J Immunol March 1, 1980, 124 (3) 1122-1129;
  • You have accessRestricted access
    Is experimental autoimmune myasthenia gravis induced only by acetylcholine receptors?
    T R Claudio and M A Raftery
    J Immunol March 1, 1980, 124 (3) 1130-1140;
  • You have accessRestricted access
    The use of cellular immunoadsorbents to prepare antibody that distinguishes between syngeneic surface antigens on two guinea pig hepatocarcinomas.
    H L Mathews, M J Brunda and P Minden
    J Immunol March 1, 1980, 124 (3) 1141-1147;
  • You have accessRestricted access
    Antigenic features of myelin basic protein-like material in cerebrospinal fluid.
    J N Whitaker, R M Bashir, C H Chou and R F Kibler
    J Immunol March 1, 1980, 124 (3) 1148-1153;
  • You have accessRestricted access
    Serum antibodies to human fetal antigens in patients with systemic lupus erythematosus (SLE).
    M Linker-Israeli, F P Quismorio Jr, D K Wong and G J Friou
    J Immunol March 1, 1980, 124 (3) 1154-1159;
  • You have accessRestricted access
    Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants.
    A K Abbas, L L Perry, B A Bach and M I Greene
    J Immunol March 1, 1980, 124 (3) 1160-1166;
  • You have accessRestricted access
    Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.
    H A Verbrugh, W C van Dijk, R Peters, M E van Erne, M R Daha, P K Peterson and J Verhoef
    J Immunol March 1, 1980, 124 (3) 1167-1173;
  • You have accessRestricted access
    Immunoglobulin production and secretion by variant clones of the MOPC 315 mouse myeloma cell line.
    L Winberry, A Marks and R Baumal
    J Immunol March 1, 1980, 124 (3) 1174-1182;
  • You have accessRestricted access
    Lymphocyte function in experimental African trypanosomiasis. III. Loss of lymph node cell responsiveness.
    S R Wellhausen and J M Mansfield
    J Immunol March 1, 1980, 124 (3) 1183-1186;
  • You have accessRestricted access
    Nature of hapten-modified determinants involved in induction of T cell tolerance and suppressor T cells to NDFB contact sensitivity.
    S D Miller, P J Conlon, M S Sy, J W Moorhead, S Colón, H M Grey and H N Claman
    J Immunol March 1, 1980, 124 (3) 1187-1193;
  • You have accessRestricted access
    Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
    I Kaneko, D T Fearon and K F Austen
    J Immunol March 1, 1980, 124 (3) 1194-1198;
  • You have accessRestricted access
    Lymphotoxin production by subsets of T cells.
    D D Eardley, F W Shen, R K Gershon and N H Ruddle
    J Immunol March 1, 1980, 124 (3) 1199-1202;
  • You have accessRestricted access
    Diversity of cell surface polypeptides that are recognized by heteroantisera to human T cells.
    P Niaudet and M Greaves
    J Immunol March 1, 1980, 124 (3) 1203-1208;
  • You have accessRestricted access
    Progressive myelopathy in older German shepherd dogs. I. Depressed response to thymus-dependent mitogens.
    F J Waxman, R M Clemmons, G Johnson, J F Evermann, M I Johnson, C Roberts and D J Hinrichs
    J Immunol March 1, 1980, 124 (3) 1209-1215;
  • You have accessRestricted access
    Progressive myelopathy in older German shepherd dogs. II. Presence of circulating suppressor cells.
    F J Waxman, R M Clemmons and D J Hinrichs
    J Immunol March 1, 1980, 124 (3) 1216-1222;
  • You have accessRestricted access
    Regulation of lipopolysaccharide-induced granulopoiesis and macrophage formation by spleen cells. II. Macrophage-lymphocyte interactions in the process of generation of colony-stimulating factor.
    R N Apte, C F Hertogs and D H Pluznik
    J Immunol March 1, 1980, 124 (3) 1223-1229;
  • You have accessRestricted access
    Maintenance of immunologic unresponsiveness to human gamma-globulin: evidence for irreversible inactivation in B lymphocytes.
    D E Parks and W O Weigle
    J Immunol March 1, 1980, 124 (3) 1230-1236;
  • You have accessRestricted access
    Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens.
    G S Eisenbarth, B F Haynes, J A Schroer and A S Fauci
    J Immunol March 1, 1980, 124 (3) 1237-1244;
  • You have accessRestricted access
    Use of immunotolerance to dissect the mechanisms regulating appearance of hapten-specific killer T cells in vivo.
    L D Butler, H L Wong and J R Battisto
    J Immunol March 1, 1980, 124 (3) 1245-1250;
  • You have accessRestricted access
    Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharide.
    D R Schultz, M Loos, F Bub and P I Arnold
    J Immunol March 1, 1980, 124 (3) 1251-1257;
  • You have accessRestricted access
    H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    L R Gooding and C B Edwards
    J Immunol March 1, 1980, 124 (3) 1258-1262;
  • You have accessRestricted access
    Antigen-specific factors produced by carrier-primed New Zealand Black mice.
    S Sawada, M J Dauphinée and N Talal
    J Immunol March 1, 1980, 124 (3) 1263-1266;
  • You have accessRestricted access
    Partial purification and characterization of trypsin-solubilized rat kidney antigens that stimulate the production of teratogenic antibodies.
    C C Leung and R L Brent
    J Immunol March 1, 1980, 124 (3) 1267-1270;
  • You have accessRestricted access
    Studies on in vivo priming to TNP-reactive cytotoxic effector cell system. II. Augmented secondary cytotoxic response by radioresistant T cells and demonstration of differential helper activity as a function of the stimulating dose of TNP-self.
    H Fujiwara and G M Shearer
    J Immunol March 1, 1980, 124 (3) 1271-1276;
  • You have accessRestricted access
    Nonspecific inhibition of encephalomyocarditis virus replication by a type II interferon released from unstimulated cells of Mycobacterium tuberculosis-sensitized mice.
    A M Pusateri, L C Ewalt and D L Lodmell
    J Immunol March 1, 1980, 124 (3) 1277-1283;
  • You have accessRestricted access
    Differential sensitivity of IgG memory subpopulations to allogeneic thymocytes: positive and negative signals.
    H Golding and M B Rittenberg
    J Immunol March 1, 1980, 124 (3) 1284-1290;
  • You have accessRestricted access
    The ninth component of human complement: purification and physicochemical characterization.
    G Biesecker and H J Müller-Eberhard
    J Immunol March 1, 1980, 124 (3) 1291-1296;
  • You have accessRestricted access
    Reduced natural killer activity in female mice after neonatal exposure to diethylstilbestrol.
    T Kalland
    J Immunol March 1, 1980, 124 (3) 1297-1300;
  • You have accessRestricted access
    A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.
    E L Reinherz, P C Kung, G Goldstein and S F Schlossman
    J Immunol March 1, 1980, 124 (3) 1301-1307;
  • You have accessRestricted access
    Dissociation of differentiation and proliferation in the primary induction of cytolytic T lymphocytes by alloantigens.
    H R MacDonald and R K Lees
    J Immunol March 1, 1980, 124 (3) 1308-1313;
  • You have accessRestricted access
    Characterization of the stimulator cells in the murine primary mixed leukocyte response.
    M Minami, D C Shreffler and C Cowing
    J Immunol March 1, 1980, 124 (3) 1314-1321;
  • You have accessRestricted access
    Lymphocytes bearing Fc receptors for IgE. IV. Formation of IgE-binding factor by rat T lymphocytes.
    J Yodoi and K Ishizaka
    J Immunol March 1, 1980, 124 (3) 1322-1329;
  • You have accessRestricted access
    Polyclonal activation of murine B lymphocytes by Fc fragments. I. The requirement for two signals in the generation of the polyclonal antibody response induced by Fc fragments.
    E L Morgan and W O Weigle
    J Immunol March 1, 1980, 124 (3) 1330-1335;
  • You have accessRestricted access
    Minimum peptide sequences necessary for priming and triggering of humoral and cell-mediated immune responses in mice: use of synthetic peptide antigens of defined structure.
    B Singh, K C Lee, E Fraga, A Wilkinson, M Wong and M A Barton
    J Immunol March 1, 1980, 124 (3) 1336-1343;
  • You have accessRestricted access
    Comparison of T and B cell reactivity to antigens under Ir gene control.
    T J Kipps, J Z Weinberger, B Benacerraf and M E Dorf
    J Immunol March 1, 1980, 124 (3) 1344-1349;
  • You have accessRestricted access
    Two types of functionally distinct, synergizing helper T cells.
    D M Keller, J E Swierkosz, P Marrack and J W Kappler
    J Immunol March 1, 1980, 124 (3) 1350-1359;
  • You have accessRestricted access
    Relationship between enhanced macrophage phagocytic activity and the induction of interferon by Newcastle disease virus in mice.
    S I Hamburg, G H Cassell and M Rabinovitch
    J Immunol March 1, 1980, 124 (3) 1360-1364;
  • You have accessRestricted access
    Alveolar macrophage suppression of canine bronchoalveolar lymphocytes: the role of prostaglandin E2 in the inhibition of mitogen-responses.
    J H Demenkoff, M J Ansfield, H B Kaltreider and E Adam
    J Immunol March 1, 1980, 124 (3) 1365-1370;
  • You have accessRestricted access
    Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses.
    W L Farrar, S B Mizel and J J Farrar
    J Immunol March 1, 1980, 124 (3) 1371-1377;
  • You have accessRestricted access
    Bactericidal activity of eosinophil peroxidase.
    E C Jong, W R Henderson and S J Klebanoff
    J Immunol March 1, 1980, 124 (3) 1378-1382;
  • You have accessRestricted access
    Binding of eosinophil peroxidase to mast cell granules with retention of peroxidatic activity.
    W R Henderson, E C Jong and S J Klebanoff
    J Immunol March 1, 1980, 124 (3) 1383-1388;
  • You have accessRestricted access
    Immune suppression in vivo with antigen-modified syngeneic cells. IV. Requirement for Ia+ adherent cells for induction.
    D H Sherr, K M Heghinian, B Benacerraf and M E Dorf
    J Immunol March 1, 1980, 124 (3) 1389-1395;
  • You have accessRestricted access
    Comparative studies on the binding properties of human and rabbit C-reactive proteins.
    E B Oliveira, E C Gotschlich and T Y Liu
    J Immunol March 1, 1980, 124 (3) 1396-1402;
  • You have accessRestricted access
    Heterogeneity of human suppressor cells induced by concanavalin A as determined in simultaneous assays of immune function.
    H B Herscowitz, T Sakane, A D Steinberg and I Green
    J Immunol March 1, 1980, 124 (3) 1403-1410;
  • You have accessRestricted access
    A mature T lymphocyte marker closely linked to Igh-1 that is expressed on the precursor for the suppressor T cell regulating a primary response to SRBC.
    F L Owen
    J Immunol March 1, 1980, 124 (3) 1411-1417;
  • You have accessRestricted access
    The first component of complement from the bullfrog, Rana catesbeiana: functional properties of C1- and isolation of subcomponent C1q.
    R J Alexander and L A Steiner
    J Immunol March 1, 1980, 124 (3) 1418-1425;
  • You have accessRestricted access
    Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli.
    D I Beller, J M Kiely and E R Unanue
    J Immunol March 1, 1980, 124 (3) 1426-1432;
  • You have accessRestricted access
    IA antigens and antigen-presenting function of thymic macrophages.
    D I Beller and E R Unanue
    J Immunol March 1, 1980, 124 (3) 1433-1440;
  • You have accessRestricted access
    Interactions between human eosinophils and schistosomula of Schistosoma mansoni. I. Stable and irreversible antibody-dependent adherence.
    M A Vadas, A E Butterworth, B Sherry, A Dessein, M Hogan, D Bout and J R David
    J Immunol March 1, 1980, 124 (3) 1441-1448;
  • You have accessRestricted access
    Human T lymphocyte surface antigens: partial purification and characterization utilizing a high-titer heteroantiserum.
    D M Pratt, S F Schlossman and J L Strominger
    J Immunol March 1, 1980, 124 (3) 1449-1461;
  • You have accessRestricted access
    Characterization of guinea pig lymphocyte-derived chemotactic factor for fibroblasts.
    A E Postlethwaite and A H Kang
    J Immunol March 1, 1980, 124 (3) 1462-1466;
  • You have accessRestricted access
    Neutrophil degranulation and abnormal chemotaxis after thermal injury.
    J M Davis, P Dineen and J I Gallin
    J Immunol March 1, 1980, 124 (3) 1467-1471;
  • You have accessRestricted access
    Flow sorting of antigen-binding B cell subsets.
    J L Greenstein, J Leary, P Horan, J W Kappler and P Marrack
    J Immunol March 1, 1980, 124 (3) 1472-1481;
  • You have accessRestricted access
    Induction of a transient elevation in intracellular levels of adenosine-3',5'-cyclic monophosphate by chemotactic factors: an early event in human neutrophil activation.
    L Simchowitz, L C Fischbein, I Spilberg and J P Atkinson
    J Immunol March 1, 1980, 124 (3) 1482-1491;
  • You have accessRestricted access
    H-2-linked Ir gene control of T cell proliferative responses to the synthetic terpolymer L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). I. Requirements for T cell activation in responder and nonresponder mice.
    B A Araneo and J A Kapp
    J Immunol March 1, 1980, 124 (3) 1492-1498;
  • You have accessRestricted access
    Hybridoma autoantibodies to DNA.
    C Andrzejewski Jr, B D Stollar, T M Lalor and R S Schwartz
    J Immunol March 1, 1980, 124 (3) 1499-1502;
  • You have accessRestricted access
    TNP-coupled membranes stimulate T cell proliferation via the macrophage.
    E Heber-Katz and E M Shevach
    J Immunol March 1, 1980, 124 (3) 1503-1505;
  • You have accessRestricted access
    The influence of hapten-conjugated isologous mouse gamma-globulin as a tolerogen on H-2 restricted cytotoxic effector cells.
    S D Waksal and Y Borel
    J Immunol March 1, 1980, 124 (3) 1506-1509;

LETTERS TO THE EDITOR

  • You have accessRestricted access
    Revised nomenclature.
    M M Mayer and B H Waksman
    J Immunol March 1, 1980, 124 (3) 1510;
  • You have accessRestricted access
    International Lymphokine Nomenclature Committee.
    B H Waksman
    J Immunol March 1, 1980, 124 (3) 1510-1511;

ABSTRACTS

  • You have accessRestricted access
    Abstracts of papers presented at the Eighth International Complement Workshop, Key Biscayne, Florida, October 13-16, 1979.
    J Immunol March 1, 1980, 124 (3) 1512-1547;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 124, Issue 3
1 Mar 1980
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • OPINION
  • ARTICLES
  • LETTERS TO THE EDITOR
  • ABSTRACTS
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606